ODTX
Odyssey Therapeutics, Inc.
20.99
+0.99 (+4.95%)
52w low 15.10
29.05 high
42.2% of range
Financial Analysis
| (USD) | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -- | -31.26M | -25.33M | -41.03M | -34.51M | -41.54M | |
| Depreciation & Amort | -- | 1.19M | 1.16M | 1.17M | 1.04M | 1.01M | |
| Capital Expenditure | -- | -48.00K | -228.00K | -148.00K | -186.00K | -504.00K | |
| Free Cash Flow | -- | -31.30M | -25.56M | -41.18M | -34.69M | -42.05M | |
| Investing Cash Flow | -- | -172.90M | 11.53M | 34.80M | -211.44M | 43.29M | |
| Financing Cash Flow | -- | 90.78M | 5.94M | 484.00K | 292.16M | -3.18M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--